Mucosal and systemic immune responses in patients with diarrhea due to CS6-expressing enterotoxigenic Escherichia coli

Infection and Immunity

Volumn 75, Issue 5, 2007, Pages 2269-2274

  Qadri, Firdausi ^a,e   Ahmed, Tanvir ^a   Ahmed, Firoz ^a   Bhuiyan, M Saruar ^a   Mostofa, Mohammad Golam ^a   Cassels, Frederick J ^b   Helander, Anna ^c   Svennerholm, Ann Mari ^d  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e ICDDRB Laboratory Sciences Division   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CS4 PROTEIN; CS5 PROTEIN; CS6 PROTEIN; GENE PRODUCT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ADULT; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DEHYDRATION; DIARRHEA; DISEASE SEVERITY; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROCONVERSION;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; CHILD, PRESCHOOL; DIARRHEA; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FECES; FEMALE; HOSPITALIZATION; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; INFANT; MALE; MIDDLE AGED; RECOMBINANT PROTEINS;

EID: 34248373314     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01856-06     Document Type: Article

References (43)

1. Ahren, C., M. Jertborn, and A. M. Svennerholm. 1998. Intestinal immune responses to an inactivated oral enterotoxigenic Escherichia coli vaccine and associated immunoglobulin A responses in blood. Infect. Immun. 66:3311-3316.
2. Asaduzzaman, M., E. T. Ryan, M. John, L. Hang, A. I. Khan, A. S. Faruque, R. K. Taylor, S. B. Calderwood, and F. Qadri. 2004. The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139. Infect. Immun. 72:4448-4454.
3. Byrd, W., and F. J. Cassels. 2006. Intranasal immunization of BALB/c mice with enterotoxigenic Escherichia coli colonization factor CS6 encapsulated in biodegradable poly(DL-lactide-co-glycolide) microspheres. Vaccine 24:1359-1366.
4. de Lorimier, A. J., W. Byrd, E. R. Hall, W. M. Vaughan, Tang, D., Z. J. Roberts, C. E. McQueen, and F. J. Cassels. 2003. Murine antibody response to intranasally administered enterotoxigenic Escherichia coli colonization factor CS6. Vaccine 21:2548-2555.
5. Favre, D., S. Ludi, M. Stoffel, J. Frey, M. P. Horn, G. Dietrich, S. Spreng, and J. F. Viret. 2006. Expression of enterotoxigenic Escherichia coli colonization factors in Vibrio cholerae. Vaccine 24:4354-4368.
6. Field, M., L. H. Graf, Jr., W. J. Laird, and P. L. Smith. 1978. Heat-stable enterotoxin of Escherichia coli: in vitro effects on guanylate cyclase activity, cyclic GMP concentration, and ion transport in small intestine. Proc. Natl. Acad. Sci. USA 75:2800-2804.
7. Gaastra, W., and A. M. Svennerholm. 1996. Colonization factors of human enterotoxigenic Escherichia coli (ETEC). Trends Microbiol. 4:444-452.
8. Girard, M. P., D. Steele, C. L. Chaignat, and M. P. Kieny. 2006. A review of vaccine research and development: human enteric infections. Vaccine 24: 2732-2750.
9. Guerena-Burgueno, F., E. R. Hall, D. N. Taylor, F. J. Cassels, D. A. Scott, M. K. Wolf, Z. J. Roberts, G. V. Nesterova, C. R. Alving, and G. M. Glenn. 2002. Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously. Infect. Immun. 70:1874-1880.
10. Helander, A., H. M. Grewal, W. Gaastra, and A. M. Svennerholm. 1997. Detection and characterization of the coli surface antigen 6 of enterotoxigenic Escherichia coli strains by using monoclonal antibodies. J. Clin. Microbiol. 35:867-872.
11. Helander, A., G. C. Hansson, and A. M. Svennerholm. 1997. Binding of enterotoxigenic Escherichia coli to isolated enterocytes and intestinal mucus. Microb. Pathog. 23:335-346.
12. Helander, A., C. Wenneras, F. Qadri, and A. M. Svennerholm. 1998. Antibody responses in humans against coli surface antigen 6 of enterotoxigenic Escherichia coli. Infect. Immun. 66:4507-4510.
13. Jertborn, M., C. Ahren, and A. M. Svennerholm. 2001. Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine. Clin. Diagn. Lab. Immunol. 8:424-428.
14. Katz, D. E., A. J. DeLorimier, M. K. Wolf, E. R. Hall, F. J. Cassels, J. E. van Hamont, R. L. Newcomer, M. A. Davachi, D. N. Taylor, and C. E. McQueen. 2003. Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen. Vaccine 21:341-346.
15. Levine, M. M. 1990. Modern vaccines. Enteric infections. Lancet 335:958-961.
16. McKenzie, R., A. L. Bourgeois, F. Engstrom, E. Hall, H. S. Chang, J. G. Gomes, J. L. Kyle, F. Cassels, A. K. Turner, R. Randall, M. Darsley, C. Lee, P. Bedford, J. Shimko, and D. A. Sack. 2006. Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults. Infect. Immun. 74:994-1000.
17. Qadri, F., F. Ahmed, T. Ahmed, and A. M. Svennerholm. 2006. Homologous and cross-reactive immune responses to enterotoxigenic Escherichia coli colonization factors in Bangladeshi children. Infect. Immun. 74:4512-4518.
18. Qadri, F., T. Ahmed, F. Ahmed, Y. A. Begum, D. A. Sack, and A. M. Svennerholm. 2006. Reduced dose of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6-17 months of age: dosing studies in different age groups. Vaccine 24:1726-1733.
19. Qadri, F., T. Azim, A. Chowdhury, J. Hossain, R. B. Sack, and M. J. Albert. 1994. Production, characterization, and application of monoclonal antibodies to Vibrio cholerae O139 synonym Bengal. Clin. Diagn. Lab. Immunol. 1:51-54.
20. Qadri, F., M. I. Chowdhury, S. M. Faruque, M. A. Salam, T. Ahmed, Y. A. Begum, A. Saha, M. S. Alam, K. Zaman, L. V. Seidlein, E. Park, K. P. Killeen, J. J. Mekalanos, J. D. Clemens, and D. A. Sack. 2005. Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh. J. Infect. Dis. 192:573-579.
21. Qadri, F., S. K. Das, A. S. Faruque, G. J. Fuchs, M. J. Albert, R. B. Sack, and A. M. Svennerholm. 2000. Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh. J. Clin. Microbiol. 38:27-31.
22. Qadri, F., G. Jonson, Y. A. Begum, C. Wenneras, M. J. Albert, M. A. Salam, and A. M. Svennerholm. 1997. Immune response to the mannose-sensitive hemagglutinin in patients with cholera due to Vibrio cholerae O1 and O0139. Clin. Diagn. Lab. Immunol. 4:429-434.
23. Qadri, F., E. T. Ryan, A. S. Faruque, F. Ahmed, A. I. Khan, M. M. Islam, S. M. Akramuzzaman, D. A. Sack, and S. B. Calderwood. 2003. Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers. Infect. Immun. 71:4808-4814.
24. Qadri, F., A. M. Svennerholm, A. S. Faruque, and R. B. Sack. 2005. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin. Microbiol. Rev. 18: 465-483.
25. Qadri, F., C. Wenneras, F. Ahmed, M. Asaduzzaman, D. Saha, M. J. Albert, R. B. Sack, and A. Svennerholm. 2000. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children. Vaccine 18:2704-2712.
26. Qadri, F., C. Wenneras, M. J. Albert, J. Hossain, K. Mannoor, Y. A. Begum, G. Mohi, M. A. Salam, R. B. Sack, and A. M. Svennerholm. 1997. Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1. Infect. Immun. 65:3571-3576.
27. Rao, M. R., R. Abu-Elyazeed, S. J. Savarino, A. B. Nancy, T. F. Wierzba, I. Abdel-Messih, H. Shaheen, R. W. Frenck, Jr., A. M. Svennerholm, and J. D. Clemens. 2003. High disease burden of diarrhea due to enterotoxigenic Escherichia coli among rural Egyptian infants and young children. J. Clin. Microbiol. 41:4862-4864.
28. Rao, M. R., T. F. Wierzba, S. J. Savarino, R. Abu-Elyazeed, N. El-Ghoreb, E. R. Hall, A. Nancy, I. Abdel-Messih, R. W. Frenck, Jr., A. M. Svennerholm, and J. D. Clemens. 2005. Serologic correlates of protection against enterotoxigenic Escherichia coli diarrhea. J. Infect. Dis. 191:562-570.
29. Rockabrand, D. M., H. I. Shaheen, S. B. Khalil, L. F. Peruski, Jr, P. J. Rozmajzl, S. J. Savarino, M. R. Monteville, R. W. Frenck, A. M. Svennerholm, S. D. Putnam, and J. W. Sanders. 2006. Enterotoxigenic Escherichia coli colonization factor types collected from 1997 to 2001 in US military personnel during operation Bright Star in northern Egypt. Diagn. Microbiol. Infect. Dis. 55:9-12.
30. Sixma, T. K., K. H. Kalk, B. A. van Zanten, Z. Dauter, J. Kingma, B. Witholt, and W. G. Hol. 1993. Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin. J. Mol. Biol. 230:890-918.
31. Steinsland, H., P. Valentiner-Branth, H. K. Gjessing, P. Aaby, K. Molbak, and H. Sommerfelt. 2003. Protection from natural infections with enterotoxigenic Escherichia coli: longitudinal study. Lancet 362:286-291.
32. Svennerholm, A. M., and J. Holmgren. 1995. Oral vaccines against cholera and enterotoxigenic Escherichia coli diarrhea. Adv. Exp. Med. Biol. 371B: 1623-1628.
33. Svennerholm, A. M., M. Jertborn, L. Gothefors, A. M. Karim, D. A. Sack, and J. Holmgren. 1984. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J. Infect. Dis. 149:884-893.
34. Svennerholm, A. M., Y. L. Vidal, J. Holmgren, M. M. McConnell, and B. Rowe. 1988. Role of PCF8775 antigen and its coli surface subcomponents for colonization, disease, and protective immunogenicity of enterotoxigenic Escherichia coli in rabbits. Infect. Immun. 56:523-528.
35. Svennerholm, A. M., M. Wikstrom, M. Lindblad, and J. Holmgren. 1986. Monoclonal antibodies against Escherichia coli heat-stable toxin (STa) and their use in a diagnostic ST ganglioside GM1-enzyme-linked immunosorbent assay. J. Clin. Microbiol. 24:585-590.
36. Turner, A. K., J. C. Beavis, J. C. Stephens, J. Greenwood, C. Gewert, N. Thomas, A. Deary, G. Casula, A. Daley, P. Kelly, R. Randall, and M. J. Darsley. 2006. Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I. Infect. Immun. 74:1062-1071.
37. Turner, A. K., T. D. Terry, D. A. Sack, P. Londono-Arcila, and M. J. Darsley. 2001. Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans. Infect. Immun. 69:4969-4979.
38. Wenneras, C., F. Qadri, P. K. Bardhan, R. B. Sack, and A. M. Svennerholm. 1999. Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees. Infect. Immun. 67:6234-6241.
39. WHO. 1990. Manual for the treatment of diarrhoea: for use by physicians and other senior healthworkers. WOH/CDD/SER/80-2, revision 2. World Health Organization, Geneva, Switzerland.
40. WHO. 1987. Manual for laboratory investigations of acute enteric infections, p. 9-20. World Health Organization, Geneva, Switzerland.
41. Wolf, M. K. 1997. Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli. Clin. Microbiol. Rev. 10:569-584.
42. Wolf, M. K., L. A. de Haan, F. J. Cassels, G. A. Willshaw, R. Warren, E. C. Boedeker, and W. Gaastra. 1997. The CS6 colonization factor of human enterotoxigenic Escherichia coli contains two heterologous major subunits. FEMS Microbiol. Lett. 148:35-42.
43. Yu, J., F. Cassels, T. Scharton-Kersten, S. A. Hammond, A. Hartman, E. Angov, B. Corthesy, C. Alving, and G. Glenn. 2002. Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli. Infect. Immun. 70:1056-1068.